Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients
Clinical trial NCT01646671 · COMPLETED
Trial details
- NCT number
- NCT01646671
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-02-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.